# Selank FAQ: Mechanism, GABA, Serotonin, Safety & Legality > Selank FAQ: direct, cited answers on how Selank works, its effects on GABA, serotonin, dopamine, and BDNF, its immune activity, its safety, and its regulatory status. Twenty-two questions on mechanism, effects, safety, and status — each answered plainly and tied to the literature. ## Does Selank affect serotonin and dopamine? Yes, in animal studies. Selank changed the content of monoamines (serotonin and dopamine) and their metabolites in mouse brain in a strain-dependent manner [9], and it was used to correct measures of integrative brain activity and biogenic amine levels in rats [8]. Selank and tuftsin produced comparable effects on serotonin metabolism in rat brain [10]. These are rodent neurochemistry findings, not measured human outcomes. ## What is Selank? Selank is a synthetic tuftsin-analog heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro; also called TP-7), developed in Russia and studied as a non-benzodiazepine anxiolytic and nootropic. Its anxiolytic activity is attributed largely to positive allosteric modulation of GABA receptor binding, which differs in mechanism from benzodiazepines [1]. It is not FDA-approved [6]. ## What does Selank do? In research, Selank reduces anxiety-related behavior without the sedation of benzodiazepines, acting as a positive allosteric modulator of GABA receptor binding [1]. It also inhibits enkephalin-degrading enzymes [2], increases hippocampal BDNF in rats [3], shifts monoamine turnover [9], and modulates immune cytokines [5]. It does not, on this evidence, constitute a treatment for any diagnosed condition. ## What is Selank peptide used for? In the research literature, the Selank peptide is studied principally as an anxiolytic and nootropic, with a mechanism centered on positive allosteric modulation of GABA receptor binding distinct from benzodiazepines [1]. Russian clinical studies investigated it in generalized anxiety disorder [6]. It is a research chemical in the United States, not an approved therapy, and is studied in research contexts only. ## How does Selank work? Selank works through several non-benzodiazepine mechanisms. It is a positive allosteric modulator of GABA receptor binding [1], inhibits enkephalin-degrading enzymes to stabilize the body's anti-stress peptides [2], shifts GABA-pathway gene expression [4], and modulates BDNF [3] and monoamines [9]. No single receptor fully accounts for its effects; it engages multiple systems. ## Does Selank affect GABA receptors? Yes. The central mechanistic claim is that Selank acts as a positive allosteric modulator of GABA receptor binding, with subtype-selective, concentration-dependent modulation that differs from benzodiazepines, and it can block the modulatory activity of diazepam and olanzapine [1]. It also altered the expression of GABAergic-system genes in rat frontal cortex [4]. ## Is Selank a nootropic? Selank is studied as a nootropic — a compound examined for effects on cognition — in addition to its anxiolytic framing. In rats it was used to correct integrative brain activity and biogenic amine levels [8] and showed compensatory effects on neurotoxin-impaired memory [13]. These are animal-model findings, not demonstrated cognitive enhancement in healthy people. ## What is Selank used for in research? Research uses Selank to study anxiolytic mechanisms, neuroplasticity, monoamine regulation, and immune modulation. In patients with anxiety-asthenic disorders it altered Th1/Th2 cytokine balance and modulated IL-6, characterizing it as an immunomodulator alongside its anxiolytic action [5]. It is investigated, not approved, and used in research contexts only. ## What is the difference between Selank and Semax? They are different peptides. Selank is a tuftsin-analog heptapeptide (TP-7) studied mainly as an anxiolytic [2]; Semax is a separate ACTH-fragment-derived peptide studied mainly as a nootropic and neuroprotectant. Where compared directly in a 6-OHDA rat model, the two affected behavior with distinct profiles [11]. They are not interchangeable. ## How does Selank differ from benzodiazepines for anxiety? Selank acts as a positive allosteric modulator of GABA receptor binding rather than as a classical benzodiazepine, and it can even block benzodiazepine modulatory activity at overlapping sites [1]. Russian clinical reports describe an anxiolytic effect comparable to a benzodiazepine comparator but without the sedation, cognitive impairment, or dependence [6]. This is preliminary, single-region human evidence. ## Is Selank addictive or does it cause withdrawal? The Russian clinical literature reports an anxiolytic effect without the dependence signal seen with benzodiazepines [6], and community reports describe no tolerance escalation or withdrawal syndrome on stopping. However, this rests on short-term and anecdotal experience, not long human safety trials, so the long-term picture is not established. Psychological reliance on any anxiety-reducing agent remains possible. ## Does Selank affect gene expression? Yes, in rats. Selank administration (300 µg/kg) changed the expression of genes involved in GABAergic neurotransmission in the frontal cortex — 45 genes one hour after dosing and 22 at three hours — and the direction of those shifts correlated positively with changes produced by GABA itself [4]. This is a rodent gene-expression finding. ## Does Selank increase BDNF in the hippocampus? Yes, in rats. Intranasal administration of Selank regulated (increased) BDNF expression in the hippocampus in vivo, linking the peptide to neurotrophic, neuroplasticity-related signaling [3]. BDNF is a growth factor supporting neuron survival and plasticity. This finding is from rodent work and has not been replicated as a measured human outcome. ## Does Selank help with memory and focus? In animal injury models, Selank showed a compensatory effect on memory functions disturbed by the neurotoxin MPTP in rats [13] and a protective effect in a related memory-impairment model [14], with hippocampal BDNF as one proposed substrate [3]. Community members report subjectively steadier focus once anxiety quiets, but that is anecdotal and not measured cognitive performance. ## How does Selank modulate the immune system? As a tuftsin analogue, Selank shifts Th1/Th2 cytokine balance and modulates IL-6 expression in patients with anxiety-asthenic disorders, which is why it is described as an immunomodulator [5]. It also influenced cytokine levels under stress in rats [18] and showed antiviral activity in experimental influenza in mice [19]. The clinical consequences of this in long-term human use are unstudied. ## How does Selank affect cytokine levels under stress? In rats under stress, Selank modulated cytokine levels, supporting an immunomodulatory role under stress load [18]. In patients with anxiety-asthenic disorders it shifted the Th1/Th2 cytokine balance and modulated IL-6 [5]. These findings characterize Selank as acting on immune signaling in addition to its anxiolytic effects, though human long-term implications are not established. ## Has Selank been studied for alcohol or opioid withdrawal? The cited record does not establish Selank as a treatment for alcohol or opioid withdrawal. Its enkephalinase-inhibition mechanism engages the endogenous opioid (enkephalin) system [2], and a stress-model study found diazepam combined with Selank most effective at reducing anxiety [7], but these do not amount to withdrawal-treatment evidence. No such indication is approved or demonstrated here. ## Is Selank FDA approved? No. Selank is not approved by the FDA (or EMA) for any indication; its regulatory registration as an anxiolytic exists essentially only in Russia, and in the United States it is sold strictly as a research chemical [6]. The published human efficacy data come almost entirely from single-region Russian trials with limited independent replication. ## Is Selank legal in the United States? Selank is not an approved drug in the United States and is sold only as a research chemical, not as a medicine or supplement [6]. It is described here strictly in research contexts. This site reports its regulatory status as a fact and does not offer legal advice; it is not approved for any clinical use. ## How long does Selank take to work? Controlled human onset data are not well characterized in mainstream literature. Community reports describe noticing an effect within roughly 20 to 40 minutes with intranasal use, consistent with the intranasal route producing central effects comparable to systemic dosing in mice [12]; longer-term mood changes are reported over one to two weeks. The onset figures are anecdotal, and the human PK gap is real [6]. ## Does Selank have effects on the gut or stomach? In rats, the synthetic anxiolytic Selank affected gastric wall blood flow and supported gastric mucosal protection [15]. This is a rodent physiology finding and is not a demonstration of any gastrointestinal benefit in humans. It is reported here as part of Selank's broad, multi-system activity profile rather than as a use-case. ## Should Semax and Selank be taken together in research? There is no rigorous controlled human study establishing the safety or efficacy of combining Semax and Selank; any such pairing is anecdotal and unproven. Because Selank acts across GABAergic, opioid, monoaminergic, and immune systems [1][2][9][5], adding a second active peptide raises plausible, unstudied interaction concerns. This site makes no recommendation to combine them and emphasizes that both are research chemicals, not approved therapies. --- A verification-minded reading of the Selank record — the GABA, enkephalinase and monoamine findings logged to source and tagged by evidence strength, the single-region Russian base and unknown human pharmacokinetics named without flinching; no clinic behind the console, and nothing here dispensed or sold.